全球纳米药物给药市场 – 行业趋势及 2028 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

全球纳米药物给药市场 – 行业趋势及 2028 年预测

  • Healthcare
  • Upcoming Report
  • Nov 2024
  • Global
  • 350 页面
  • 桌子數: 220
  • 图号: 60

Global Nanomedicine For Drug Delivery Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2025 –2032
Diagram Market Size (Base Year)
USD 275.39 Billion
Diagram Market Size (Forecast Year)
USD 675.56 Billion
Diagram CAGR
%
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

全球纳米药物给药市场,按方式(诊断、治疗)、产品类型(纳米粒子、纳米壳、纳米管、纳米装置)、适应症(肿瘤疾病、传染病、心血管疾病、骨科疾病、神经系统疾病、泌尿系统疾病、眼科疾病、免疫疾病、其他)、国家(美国、加拿大、墨西哥、德国、意大利、英国、法国、西班牙、荷兰、比利时、瑞士、土耳其、俄罗斯、欧洲其他地区、日本、中国、印度、韩国、澳大利亚、新加坡、马来西亚、泰国、印度尼西亚、菲律宾、亚太其他地区、巴西、阿根廷、南美洲其他地区、南非、沙特阿拉伯、阿联酋、埃及、以色列、中东和非洲其他地区)行业趋势和预测到 2028 年

纳米药物用于药物输送市场

纳米药物输送市场分析及见解

预计药物输送纳米药物市场将在 2021 年至 2028 年的预测期内实现市场增长。Data Bridge Market Research 分析该市场到 2028 年将达到 4313.3 亿美元,并将在上述预测期内以 11.87% 的复合年增长率增长。

纳米医学是医学的一个分支,它利用纳米技术的工具和知识来预防和治疗各种疾病。纳米医学是具有可编程特性的多功能药物,借助纳米粒子和纳米设备,可用于在分子水平上构建、监测、修复和控制生物系统。

神经系统疾病治疗的高需求是预计会加剧纳米药物药物输送市场增长和需求的重要因素之一。此外,帕金森病、阿尔茨海默病和肿瘤等神经系统疾病中口服药物吸收不足预计也会在 2021 年至 2028 年预测期内促进全球市场的增长。此外,用于治疗复杂中枢神经系统疾病的金、脂质或可生物降解纳米颗粒的需求快速增长,以及大量采用脂质体纳米颗粒来封装治疗剂,也可能促进市场的增长。此外,诊断程序中技术进步的引入和纳米药物在药物输送技术中的使用增加也是预计会推动纳米药物药物输送市场增长的重要因素之一。                         

预计在 2021 年至 2028 年的预测期内,基于纳米分子的技术和潜在产品线的引入、政府参与研发资金水平的增加以及纳米机器人的出现将为市场提供巨大的增长机会。

However, the strict regulatory guidelines and long approval process are expected to curb the growth of the nanomedicine for drug delivery market, whereas the nanomedicine based devices involves huge investment which can challenge the growth of the nanomedicine for drug delivery market.

This nanomedicine for drug delivery market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the nanomedicine for drug delivery market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Nanomedicine for Drug Delivery Market Scope and Market Size

The nanomedicine for drug delivery market is segmented on the basis of modality, product type and indication. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • On the basis of modality, the nanomedicine for drug delivery market is segmented into diagnostics and treatments.
  • On the basis of product type, the nanomedicine for drug delivery market is segmented into nanoparticles, nano-shells, nanotubes and nanodevices. Nanoparticles have further been segmented into metal and metal oxide nanoparticles, liposomes, polymers & polymer drug conjugates, hydrogel nanoparticles, dendrimers and inorganic nanoparticles.

The indication segment of nanomedicine for drug delivery market is segmented into oncological diseases, infectious diseases, cardiovascular diseases, orthopedic disorders, neurological diseases, urological diseases, ophthalmological diseases, immunological diseases and others.

 Nanomedicine for Drug Delivery Market Country Level Analysis

The nanomedicine for drug delivery market is analyzed and market size insights and trends are provided by country, modality, product type and indication as referenced above.

The countries covered in the nanomedicine for drug delivery market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.

North America region leads the nanomedicine for drug delivery market owing to the strong presence of increasingly growing partnerships among enterprises operating herein and nanomedicine startup organizations. Asia-Pacific is expected to expand at a significant growth rate over the forecast period of 2021 to 2028 because of the increase in number of research grants and rise in demand for prophylaxis of life-threatening diseases.

The country section of the nanomedicine for drug delivery market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The nanomedicine for drug delivery market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for nanomedicine for drug delivery market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the nanomedicine for drug delivery market. The data is available for historic period 2011 to 2019.

Competitive Landscape and Nanomedicine for Drug Delivery Market Share Analysis

The nanomedicine for drug delivery market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to nanomedicine for drug delivery market.

纳米药物药物输送市场报告中涉及的主要参与者包括雅培、安进基金会、阿斯利康、卡迪拉制药、新基公司、强生服务公司、梯瓦制药工业有限公司、吉利德科学公司、诺华公司、辉瑞公司、罗氏公司、武田制药有限公司、赛诺菲、百时美施贵宝公司、鲁米尼克斯公司、礼来公司、Ablynx NV、默克公司、Nanospectra Biosciences、Nanobiotix 以及其他国内和全球参与者。市场份额数据分别提供全球、北美、欧洲、亚太地区 (APAC)、中东和非洲 (MEA) 和南美。DBMR 分析师了解竞争优势并为每个竞争对手分别提供竞争分析。


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The major players in the Nanomedicine for Drug Delivery Market are Abbott, Amgen Foundation, Inc., AstraZeneca, Cadila Pharmaceuticals., Celgene Corporation, Johnson & Johnson Services, Inc., Teva Pharmaceutical Industries Ltd., Gilead Sciences, Inc., etc.
The countries covered in the Nanomedicine for Drug Delivery Market are U.S., Canada, Mexico in North America, Germany, Sweden, Poland, Denmark, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe in Europe, Japan, China, India, etc.